Login / Signup

COVID-19 vaccination and cancer immunotherapy: should they stick together?

Patrick BrestBaharia MograbiPaul HofmanGerard Milano
Published in: British journal of cancer (2021)
The combination of COVID-19 vaccination with immunotherapy by checkpoint inhibitors in cancer patients could intensify immunological stimulation with potential reciprocal benefits. Here, we examine more closely the possible adverse events that can arise in each treatment modality. Our conclusion is that caution should be exercised when combining both treatments.
Keyphrases
  • coronavirus disease
  • sars cov
  • dna damage
  • respiratory syndrome coronavirus
  • cell cycle
  • combination therapy
  • risk assessment